This study evaluated the clinical efficacy and safety of a new triazolobenzodiazepine, adinazolam, and imipramine in 40 patients with carefully diagnosed major depressive disorder. Overall, adinazolam was found to be as effective as imipramine. In addition, when patients with more severe, melancholi
Neurostimulatory and ablative treatment options in major depressive disorder: a systematic review
β Scribed by Pablo Andrade; Lieke H. M. Noblesse; Yasin Temel; Linda Ackermans; Lee W. Lim; Harry W. M. Steinbusch; Veerle Visser-Vandewalle
- Publisher
- Springer Vienna
- Year
- 2010
- Tongue
- English
- Weight
- 215 KB
- Volume
- 152
- Category
- Article
- ISSN
- 0001-6268
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Objective Approximately half of older patients treated for major depressive disorder (MDD) do not achieve symptomatic remission and functional recovery with firstβline pharmacotherapy. This study aims to characterize sociodemographic, clinical, and neuropsychologic correlates of ful
Older adults represent a growing segment of the population with the highest suicide rate and an increasing need of counseling services for major depression and dysthymia. The present study examined the literature with the purpose of identifying research addressing psychosocial treatments of depressi
## Abstract ## Objectives To review data from randomized controlled trials (RCTs) assessing the comparative efficacy of carbamazepine and lithium in treatment of acute manic and maintenance phase of bipolar disorder (BD). ## Design RCTs were identified through a search strategy that included: el
## Abstract Repetitive transcranial magnetic stimulation (rTMS) is a relatively new treatment modality for psychiatric patients. rTMS was demonstrated to be effective in the treatment of depression. However, longitudinal outcome studies have not yet been published. Relapse rates are higher in depre